15/05/2026
Canine Mammary Tumours
Several experimental peptides and targeted peptide-based therapies have shown promise in slowing the growth, reducing viability, or inhibiting the spread of mammary tumors in dogs.Here are the specific peptides and related targeted therapies identified in research:[AFPep (Alpha-Fetoprotein-Derived Peptide): This is a 9-amino acid peptide that mimics the anti-estrogenic site of alpha-fetoprotein. It has shown the ability to inhibit the growth of canine mammary cancer cells in laboratory settings and studies suggest it is well-tolerated in dogs, making it a promising candidate for further development.[Desmopressin (DDAVP): A synthetic peptide analog of vasopressin, this compound has shown anti-metastatic and anti-proliferative effects in both laboratory studies and in some canine clinical trials. It has been suggested as a potential perioperative adjuvant therapy to reduce tumor spread, although some studies have yielded mixed results regarding its overall efficacy.[αCT1 (Alpha-Connexin Carboxyl-Terminal Peptide): This peptide acts by restoring cell-to-cell communication (gap junctions) that is lost in cancer cells. It has been shown to reduce the viability of canine adenoma and adenocarcinoma cells while appearing to have no harmful effects on normal mammary cells.[Pardaxin: An antimicrobial peptide derived from marine fish, studies indicate it has significant antitumor activity against various tumors, including potential application in canine mammary cancers, acting similarly to a lytic peptide that damages tumor cell membranes.[Thrombospondin-1 (TSP-1) Mimetics (ABT-510, ABT-526): These synthetic peptides mimic the antiangiogenic properties of TSP-1, essentially starving the tumor of blood supply. Clinical evaluations have shown that these peptides are safe and can stabilize disease or cause tumor reduction in dogs with mammary carcinoma.Scorpion Venom-Derived Peptides: Specific peptides from scorpion venom have been shown to inhibit the proliferation of canine mammary gland tumor cell lines by inducing apoptosis.Important Notes:These therapies are largely experimental or in advanced preclinical stages, rather than standard, widely available veterinary treatments.Surgery remains the primary, most effective treatment for canine mammary tumors.Immunocidin is a veterinary biological product used to treat mixed mammary tumors and adenocarcinomas, though it is not a pure peptide.